Robert I. Tepper, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 15,000 shares at $16.00 ($240K) on 2017-06-29, disclosed to the SEC on 2017-06-30.
Open-market sale of $240k CTMX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RVMD | SELL | 2021-06-07 | $32.8M | — | Filing → |
| RLAY | SELL | 2021-01-14 | $312.2M | — | Filing → |
| JNCE | SELL | 2020-11-23 | $105K | — | Filing → |